Login to Your Account

Biotech industry still in a cooling off period

By Cormac Sheridan
Staff Writer

Monday, November 6, 2017

BERLIN – The biotech industry is still cooling down from the high temperatures it reached in 2014 and 2015. R&D-stage acquisition deals and R&D-stage out-licensing deals are both well off their recent peaks, David Thomas, senior director, industry research and analysis at the Biotechnology Innovation Organization told delegates.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription